Send the following on WhatsApp
Continue to Chathttps://es.marketscreener.com/cotizacion/accion/CYNATA-THERAPEUTICS-LIMIT-14942262/noticia/Cynata-Therapeutics-Limited-recibe-la-aprobaci-n-del-CEI-para-el-ensayo-cl-nico-de-fase-2-propuest-42845039/?utm_source=whatsapp&utm_medium=social&utm_campaign=share